Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of mutations in blood cancer-related genes on clinical outcomes in chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 tyrosine kinase inhibitors ( TKIs) in the Ascembl trial
    Meeting Abstract

    Branford, S.; Hochhaus, A.; Mauro, M.; Minami, Y.; Rea, D.; Freitas, Cmbd; Serrano-Fernandez, P.; Obourn, V.; Bruederle, A.; Espurz, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • UBA1 mutations identify a rare but distinct subtype of myelodysplastic syndromes
    Meeting Abstract

    Sirenko, M.; Bernard, E.; Creignou, M.; Domenico, D.; Farina, A.; Ossa, J. E. A.; Kosmider, O.; Hasserjian, R.; Jädersten, M.; Germing, U.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Development of a fully immunocompetent adoptive transfer in vivo model of Npm1(cA); Idh2(R140Q); Flt3(ITD) AML
    Meeting Abstract

    Sharpe, C.; Johnson, M.; Fobare, S.; Elgamal, O. A.; Harrington, B. K.; Mustonen, A.; Bryant, K.; Cheney, C.; Lerma, J. R.; Truxall, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • What is the optimal treatment modality in molecularly defined secondary AML? A multicenter cohort study
    Meeting Abstract

    Shimony, S.; Bewersdorf, J. P.; Shallis, R. M.; Liu, Y. W.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Chen, E. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ubiquitin ligase SCF-FBXO11 controls a network of RNA-binding proteins and splicing in MDS
    Meeting Abstract

    Niederkorn, M.; Bezavada, L.; Cotton, A.; Palmer, L.; Hall, T.; Schieber, M.; Xu, P.; Weiss, M.; Rampal, R. K.; Crispino, J. D.
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic profiles and associated survival prognosticators in Black patients with acute myeloid leukemia
    Meeting Abstract

    Stiff, A.; Nicolet, D.; Fornerod, M.; Kelly, B.; Miller, K.; Mrózek, K.; Boateng, I.; Kain, B. N.; Garfinkle, E.; Hu, E. Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • TP53 Y220C mutations in patients with myeloid malignancies
    Meeting Abstract

    Gener-Ricos, G.; Bewersdorf, J. P.; Loghavi, S.; Goldberg, A. D.; Famulare, C.; Issa, G. C.; Borthakur, G.; Kadia, T. M.; Carter, B. Z.; Patel, K. P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • KOMET-008: A phase 1 study to determine the safety and tolerability of ziftomenib combinations for the treatment of KMT2A-rearranged or NPM1-mutant relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Goldberg, A. D.; Corum, D.; Ahsan, J.; Nie, K.; Kozlek, T.; Leoni, M.; Dale, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Meeting Abstract

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; Nadorp, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, in combination with venetoclax in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Meeting Abstract

    Bewersdorf, J. P.; Chandhok, N. S.; Watts, J. M.; Derkach, A.; Abdel-Wahab, O.; Stein, E. M.; Taylor, J.
    Blood (2023)

    Fulltext@MSK | Save